Proton Stereotactic Radiotherapy for Persistent Adrenocorticotropin-Producing Adenomas

Abstract

PSR is effective for patients with persistent corticotroph adenomas with low morbidity after a median follow-up of 62 months; longer follow-up is warranted for late radiation-related sequelae.